WE ASPIRE TO CURE CANCER Trademark

Trademark Overview

On Friday, May 8, 2009, a trademark application was filed for WE ASPIRE TO CURE CANCER with the United States Patent and Trademark Office. The USPTO has given the WE ASPIRE TO CURE CANCER trademark a serial number of 77732357. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, March 9, 2020. This trademark is owned by Millennium Pharmaceuticals, Inc.. The WE ASPIRE TO CURE CANCER trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services
we aspire to cure cancer

General Information

Serial Number77732357
Word MarkWE ASPIRE TO CURE CANCER
Filing DateFriday, May 8, 2009
Status800 - REGISTERED AND RENEWED
Status DateMonday, March 9, 2020
Registration Number3739198
Registration DateTuesday, January 19, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 3, 2009

Trademark Statements

Goods and ServicesPharmaceutical research and development; medical and scientific research, namely, conducting clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 12, 2009
Primary Code042
First Use Anywhere DateSunday, March 15, 2009
First Use In Commerce DateSunday, March 15, 2009

Trademark Owner History

Party NameMillennium Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, March 9, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, March 9, 2020REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, March 9, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, March 9, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, January 15, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 15, 2020TEAS SECTION 8 & 9 RECEIVED
Thursday, August 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 19, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, April 5, 2017REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, January 31, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 27, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, March 27, 2015REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, March 27, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 13, 2015TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 19, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, November 3, 2009PUBLISHED FOR OPPOSITION
Wednesday, October 14, 2009NOTICE OF PUBLICATION
Monday, September 28, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 28, 2009ASSIGNED TO LIE
Wednesday, September 16, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 3, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 31, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 31, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 14, 2009NON-FINAL ACTION MAILED
Friday, August 14, 2009NON-FINAL ACTION WRITTEN
Thursday, August 6, 2009ASSIGNED TO EXAMINER
Tuesday, May 12, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 12, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

cancer cure aspire research pharmaceutical trials scientific clinical development medical pharmaceuticals drug services